China News Service, July 10 (Reporter Chen Jing) The severity of the incidence of breast cancer has aroused widespread concern from all walks of life.
Breast-conserving treatment is of great significance to ensure the dignity of female patients and the quality of life after surgery.
The Breast Conservation Demonstration Center project was launched on July 10. On the same day, the "Breast Conservation Demonstration Center Project Launch Conference" hosted by the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association (CBCS) was held in Shanghai, and it was announced that five provinces and one city in East China and Shanxi The regional breast-conserving demonstration centers were established to provide practical guidance and reference for the clinical breast-conserving treatment of medical staff in major hospitals across the country.
The first batch of "Breast Conservation Demonstration Center Project" covers five provinces and one city in East China, as well as Beijing, Shanxi, and Hebei.
The "Breast-Conserving Demonstration Center Project" will take the lead and lead by a group of demonstration centers to help improve the level of breast-conserving treatment for breast cancer across the country, allowing more hospitals to perform breast-conserving operations and helping breast cancer patients fight the disease.
Wu Jiong, chairman of the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association and deputy dean of Fudan University Cancer Hospital, introduced: "The'Breast Conservation Demonstration Center Project' is committed to establishing 20 breast conservation demonstration centers in 2021 to allow more breasts in China. Early-stage cancer patients can receive high-quality, standardized breast-conserving treatment, which greatly improves the overall level of surgical treatment of early breast cancer in China."
It is reported that the launch of the “Breast Conservation Demonstration Center Project” can not only promote the improvement of the level of breast-conserving treatment in major domestic hospitals, but also create an environment that encourages breast-conservation and actively create conditions for breast-conserving surgery; it will also help the consensus on breast-conservation in major primary hospitals The implementation of standardized diagnosis and treatment, improve the level of domestic breast cancer surgical treatment, and increase the rate of breast-conserving treatment in China, so that Chinese breast disease patients can enjoy high-quality, standardized and humanized surgical diagnosis and treatment, and get better survival benefits and humanities care.
Lifelong Professor Shen Zhenzhou of Fudan University Cancer Hospital said in an interview that compared with many cancers, the cure rate of breast cancer is very high, and the cure rate of early-stage patients can reach more than 90%. At the same time, although breast cancer patients are cured, they face The pain of mastectomy, physical and psychological trauma is huge, breast-conserving treatment can help them regain confidence and return to society.
However, it is an indisputable fact that the surgical treatment of early breast cancer in China is still at the level of total mastectomy.
"This is not only related to early screening, the construction of a multidisciplinary comprehensive diagnosis and treatment team, etc., which has not yet reached a certain level, but the level of breast preservation rate is positively related to the per capita GDP of the area where the hospital is located and the annual operation volume of the hospital." Chinese Anti-Cancer Association for Breast Cancer Said Wang Yongsheng, deputy chairman of the professional committee and director of the Breast Disease Center of Shandong Cancer Hospital.
In the interview that day, the reporter learned that China's breast cancer disease shows the status quo of large urban-rural differences and uneven regional distribution.
Shao Zhimin, Honorary Chairman of the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association, Director of the Institute of Oncology and Breast Cancer of Fudan University, Director of General Surgery and Director of Breast Surgery, said bluntly that the uneven development of medical resources and diagnosis and treatment levels in various regions has caused many breast cancer patients to be discovered. Late stage or large tumor size, low proportion of early stage patients, many breast cancer patients have missed the best breast-conserving treatment period when they are diagnosed.
"If patients with early breast cancer receive breast-conserving treatment with less trauma, the patients can obtain comprehensive benefits both physically and mentally." Ren Guosheng emphasized.
It is understood that breast-conserving treatment of breast cancer cannot be carried out only with specialized thinking. A professional breast-conserving MDT (multidisciplinary diagnosis and treatment) team must be established, including breast surgery, breast internal medicine, radiotherapy, pathology, imaging, nursing, and plastic surgery. And other multidisciplinary collaborations, patient-centered development of optimized treatment plans.
CBCS said that hospitals at all levels need to establish a multidisciplinary system of breast-conserving MDT, so that more breast cancer patients who are conditionally breast-conserving can achieve breast-conserving treatment, and patients who are unconditional breast-conserving can strive for more breast-conservation through neoadjuvant treatment. Opportunities to maximize the prognosis of patients, and increase the breast-conservation rate and survival benefits of Chinese breast cancer patients.
(Finish)